Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

I. Journal Information

II. Scope & Description

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is a peerreviewed venue for promoting and sharing research rooted in hybridoma technology. It aims at advancing the understanding of the biology and immunology that underscores the utility of antibodies as diagnostics and therapeutics. Paramount to this aim the Journal scope includes research on the biology of B cells the production of antibodies in terms of antibody descriptions antibody engineering innovations and their use in diagnosis and therapy. Most importantly our broadened scope includes aspects of biology and immunology at the level of the antibody repertoire structural biology of antibody and modern omics techniques. Methodologically these areas may include biophysical biochemical and computational approaches as well as informatics and database development spanning the computational genomic and database resources required for analyses. In the area of diagnosis and therapy preclinical and clinical assessments of antibodies and formulations that induce or activate antibodies are welcomed. Submitted manuscripts can take the form of original research short reviews commentary and position papers.All manuscripts will adhere to the Journal guidelines that now include statement of competing interest and clarification statement of author contribution.

III. Impact Factor History

Note: impact factor data for reference only.

IV. SCImago Journal Rank (SJR)

SJR measures scientific influence, weighting citations by the prestige of the citing journal.

V. H-Index

The H-Index measures both the productivity and citation impact of a journal's publications.

How to Get Published

https://mc.manuscriptcentral.com/mab